Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.75 GBX | +2.17% | +9.30% | +19.29% |
05/04 | RUA Life Sciences expects flat annual revenue on strong second half | AN |
05/04 | RUA Life Sciences plc Provides Revenue Guidance for the Year Ended 31 March 2024 | CI |
Business Summary
Number of employees: 48
Sales per Business
GBP in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Contract Manufacture
74.6
%
| - | - | 2 | 74.6 % | - |
Biomaterials
25.4
%
| - | - | 1 | 25.4 % | - |
Sales per region
GBP in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
89.4
%
| 1 | 84.9 % | 2 | 89.4 % | +41.33% |
Switzerland
7.7
%
| - | - | 0 | 7.7 % | - |
Israel
2.2
%
| - | - | 0 | 2.2 % | - |
Italy
0.7
%
| - | - | 0 | 0.7 % | - |
United Kingdom
0.0
%
| 0 | 0.0 % | 0 | 0.0 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Lachlan Smith
DFI | Director of Finance/CFO | - | 01/21/01 |
Bill Brown
CHM | Chairman | 55 | 21/11/21 |
John McKenna
BRD | Director/Board Member | 71 | 31/16/31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Bill Brown
CHM | Chairman | 55 | 21/11/21 |
John Louis Ely
BRD | Director/Board Member | 73 | - |
Director/Board Member | 57 | 18/21/18 | |
John McKenna
BRD | Director/Board Member | 71 | 31/16/31 |
Director/Board Member | 68 | - | |
Lachlan Smith
DFI | Director of Finance/CFO | - | 01/21/01 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 62,060,272 | 49,602,446 ( 79.93 %) | 0 | 79.93 % |
Company contact information
RUA Life Sciences Plc
2 Drummond Crescent Irvine
KA11 5AN, Ayrshire
+44 12 9431 7073
http://www.aortech.comSector
Sales per Business
Sales per region
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+19.29% | 8.95M | |
+8.07% | 219B | |
+7.87% | 184B | |
+12.75% | 138B | |
-1.37% | 62.54B | |
+4.88% | 52.22B | |
+11.59% | 51.73B | |
+2.71% | 41.4B | |
+4.90% | 37.17B | |
+23.75% | 31.76B |
- Stock Market
- Equities
- AOR Stock
- Company RUA Life Sciences plc